ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 197 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $12,504,000 | -10.9% | 1,005,186 | -2.0% | 0.00% | 0.0% |
Q3 2016 | $14,038,000 | +83.4% | 1,025,365 | -1.0% | 0.00% | +100.0% |
Q2 2016 | $7,655,000 | +39.8% | 1,035,881 | +20.9% | 0.00% | 0.0% |
Q1 2016 | $5,477,000 | +0.9% | 857,131 | -1.3% | 0.00% | 0.0% |
Q4 2015 | $5,429,000 | +5.1% | 868,720 | -1.8% | 0.00% | 0.0% |
Q3 2015 | $5,166,000 | -38.9% | 884,684 | -13.5% | 0.00% | 0.0% |
Q2 2015 | $8,459,000 | +6.4% | 1,022,905 | +6.0% | 0.00% | 0.0% |
Q1 2015 | $7,953,000 | +23.8% | 965,276 | +3.2% | 0.00% | 0.0% |
Q4 2014 | $6,426,000 | +26.5% | 935,352 | -0.5% | 0.00% | +100.0% |
Q3 2014 | $5,078,000 | -59.6% | 940,410 | -52.4% | 0.00% | -50.0% |
Q2 2014 | $12,576,000 | +116.2% | 1,974,086 | +173.6% | 0.00% | 0.0% |
Q1 2014 | $5,816,000 | +19.5% | 721,605 | +1.1% | 0.00% | +100.0% |
Q4 2013 | $4,867,000 | -83.5% | 713,716 | -55.4% | 0.00% | -75.0% |
Q3 2013 | $29,468,000 | +101.5% | 1,601,544 | +91.6% | 0.00% | -20.0% |
Q2 2013 | $14,623,000 | – | 836,049 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
Geduld E E | 120,100 | $767,000 | 1.05% |
JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |